Wordt geladen...
Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program
BACKGROUND: Randomized phase III trials are ongoing to investigate the efficacy of nivolumab in malignant pleural mesothelioma (MPM), but real-world data are still scarce. In this real-world study, we investigated the clinical outcomes of nivolumab treatment in pre-treated MPM patients. METHODS: Dat...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7481613/ https://ncbi.nlm.nih.gov/pubmed/32953495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-686 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|